XTL Biopharmaceuticals Ltd. (XTLB)
1.03
-0.04
(-3.74%)
USD |
NASDAQ |
Feb 09, 10:15
XTL Biopharmaceuticals EPS Diluted (Quarterly) : -0.0292 for Dec. 31, 2024
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.6503 |
| BioLineRx Ltd. | -0.223 |
| Can-Fite BioPharma Ltd. | -- |
| Evogene Ltd. | 0.4444 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.257M |
| Revenue (Quarterly) | 0.2913M |
| Total Expenses (Quarterly) | 0.5483M |